Bio-Techne Corporation (TECH) Investment Research Dashboard
About Bio-Techne Corporation (TECH) stock analysis
Get live TECH stock price $72.17, comprehensive Bio-Techne Corporation stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time TECH stock data and investment insights.
Loading chart data...
Bio-Techne Corporation (TECH) Overview
Bio-Techne Corporation (TECH) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, TECH trades at $72.17 with a market capitalization of 11.30B . Over the past 52 weeks, TECH has traded between $43.20 and $72.39 , with the current price positioned at approximately 99% of this range . The stock currently trades...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 11.30B
- Current price: $72.17
- 52-week range: $43.20 - $72.39
- P/E ratio: 37.20
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, ...
Company Information
- CEO
- Kim Kelderman
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 3100
Contact Information
- Website
- https://www.bio-techne.com
- Address
- 614 McKinley Place N.E.
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Listed on major US exchange (NASDAQ) providing liquidity and transparency
✓ Growth-oriented company with premium valuation (P/E: 37.2)
✓ Higher growth potential with elevated volatility (Beta: 1.28)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Bio-Techne Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Bio-Techne Corporation
- ⚠Investors should consider how Bio-Techne Corporation fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 37.2) requires strong growth to justify
Market Cap
11.30B
P/E Ratio (TTM)
37.20
Beta
1.28
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare TECH with peer companies:
- Price
- $70.72+1.68% (1D)
- Market cap
- 13.67B
- Price
- $22.29-3.68% (1D)
- Market cap
- 6.30B
- Price
- $112.81+0.80% (1D)
- Market cap
- 12.19B
- Price
- $51.37+0.08% (1D)
- Market cap
- 12.91B
- Price
- $251.42+1.36% (1D)
- Market cap
- 15.79B
- Price
- $539.49+0.53% (1D)
- Market cap
- 12.46B
- Price
- $63.47+4.75% (1D)
- Market cap
- 25.18B
- Price
- $42.97+0.77% (1D)
- Market cap
- 8.86B
- Price
- $12.15-1.22% (1D)
- Market cap
- 207.83M
- Price
- $205.96+0.20% (1D)
- Market cap
- 43.79B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
88/100 ⭐⭐⭐⭐⭐
- Overall
- +0.9%
- NYSE
- +1.0%
- NASDAQ
- +0.8%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Healthcare | +0.9% | +2.1% | +4.8% | 23.5 | 88/100⭐⭐⭐⭐⭐ |
| Energy | +0.1% | +4.8% | +2.4% | 19.1 | 87/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.0% | -0.5% | +4.5% | 19.2 | 75/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +1.0% | +0.9% | +2.3% | 28.9 | 64/100⭐⭐⭐⭐ |
| Industrials | +0.5% | +2.7% | -0.2% | 31.4 | 55/100⭐⭐⭐⭐ |
| Communication Services | -1.3% | -0.9% | +1.0% | 20.7 | 52/100⭐⭐⭐ |
| Basic Materials | -1.3% | -1.1% | -0.9% | 25.1 | 32/100⭐⭐ |
| Technology | -0.3% | -0.4% | -2.0% | 44.6 | 32/100⭐⭐ |
| Consumer Cyclical | -1.2% | -0.1% | -2.1% | 44.7 | 26/100⭐⭐ |
| Real Estate | +1.2% | -0.9% | -2.5% | 27.5 | 26/100⭐⭐ |
| Utilities | -0.8% | -2.3% | -9.0% | 24.5 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-12.